Study of Tirzepatide for Recovery and Alcohol Use Management

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a pilot, 4-week, double-blind, placebo-controlled, randomized trial of individuals with alcohol use disorder (AUD) to receive weekly injections of either tirzepatide (n=10) or matching placebo (n=10). The primary aim is to determine the effects of tirzepatide on cue-reactivity among individuals with AUD. The secondary aim is to assess the safety and preliminary efficacy of tirzepatide for AUD.
Epistemonikos ID: 106284ac81fe77061991bd4263f105a198af8d07
First added on: Jan 01, 2025